1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
(
- Contribution to journal › Article
- 2024
-
Mark
Potential subtype-specific therapeutic approaches in small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Small cells – big issues : biological implications and preclinical advancements in small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Pseudomonas aeruginosa infection correlates with high MFI donor-specific antibody development following lung transplantation with consequential graft loss and shortened CLAD-free survival
(
- Contribution to journal › Article
-
Mark
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
(
- Contribution to journal › Article
- 2023
-
Mark
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
(
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
(
- Contribution to journal › Article